Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cervical Vertebrae | 6 | 2025 | 114 | 2.940 |
Why?
|
| Arnold-Chiari Malformation | 3 | 2024 | 50 | 1.140 |
Why?
|
| Thoracic Vertebrae | 2 | 2025 | 68 | 1.130 |
Why?
|
| Joint Dislocations | 1 | 2024 | 23 | 0.920 |
Why?
|
| Auditory Brain Stem Implantation | 1 | 2024 | 1 | 0.910 |
Why?
|
| Audiometry | 1 | 2024 | 21 | 0.900 |
Why?
|
| Joint Instability | 1 | 2024 | 43 | 0.880 |
Why?
|
| Neurofibromatosis 1 | 1 | 2024 | 60 | 0.880 |
Why?
|
| Scoliosis | 1 | 2024 | 133 | 0.820 |
Why?
|
| Neurosurgical Procedures | 2 | 2022 | 309 | 0.810 |
Why?
|
| Spinal Fusion | 3 | 2025 | 112 | 0.640 |
Why?
|
| Glioma | 1 | 2021 | 488 | 0.540 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 1211 | 0.460 |
Why?
|
| Pedicle Screws | 1 | 2025 | 4 | 0.240 |
Why?
|
| Kyphosis | 1 | 2025 | 22 | 0.240 |
Why?
|
| Neuroendoscopy | 1 | 2024 | 26 | 0.230 |
Why?
|
| Third Ventricle | 1 | 2024 | 27 | 0.230 |
Why?
|
| Ventriculostomy | 1 | 2024 | 35 | 0.230 |
Why?
|
| Bibliometrics | 1 | 2024 | 31 | 0.230 |
Why?
|
| Auditory Brain Stem Implants | 1 | 2024 | 2 | 0.230 |
Why?
|
| Cochlear Nerve | 1 | 2024 | 10 | 0.230 |
Why?
|
| Ribs | 1 | 2024 | 42 | 0.220 |
Why?
|
| Cavernous Sinus | 1 | 2023 | 22 | 0.220 |
Why?
|
| Biomechanical Phenomena | 1 | 2024 | 225 | 0.210 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2023 | 17 | 0.210 |
Why?
|
| Child | 8 | 2025 | 24361 | 0.210 |
Why?
|
| Neurosurgery | 1 | 2024 | 79 | 0.210 |
Why?
|
| Humans | 18 | 2025 | 124240 | 0.200 |
Why?
|
| Natural Language Processing | 1 | 2023 | 63 | 0.200 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 35 | 0.190 |
Why?
|
| Meningitis | 1 | 2022 | 98 | 0.190 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 276 | 0.190 |
Why?
|
| Down Syndrome | 1 | 2024 | 198 | 0.190 |
Why?
|
| Biology | 1 | 2021 | 29 | 0.190 |
Why?
|
| Delphi Technique | 1 | 2022 | 211 | 0.180 |
Why?
|
| Technology | 1 | 2021 | 63 | 0.180 |
Why?
|
| Clinical Decision-Making | 1 | 2023 | 265 | 0.180 |
Why?
|
| Meningioma | 1 | 2022 | 120 | 0.180 |
Why?
|
| Postoperative Care | 1 | 2022 | 295 | 0.170 |
Why?
|
| Meningeal Neoplasms | 1 | 2022 | 185 | 0.170 |
Why?
|
| Radiography | 1 | 2023 | 821 | 0.170 |
Why?
|
| Adolescent | 5 | 2025 | 19253 | 0.170 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 220 | 0.170 |
Why?
|
| Craniopharyngioma | 1 | 2019 | 33 | 0.160 |
Why?
|
| Consensus | 1 | 2022 | 640 | 0.160 |
Why?
|
| Dura Mater | 1 | 2018 | 25 | 0.150 |
Why?
|
| Pituitary Neoplasms | 1 | 2019 | 83 | 0.150 |
Why?
|
| Retrospective Studies | 7 | 2025 | 16293 | 0.150 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 90 | 0.140 |
Why?
|
| Treatment Outcome | 5 | 2025 | 12289 | 0.140 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 556 | 0.140 |
Why?
|
| Physicians | 1 | 2023 | 581 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2023 | 722 | 0.130 |
Why?
|
| Male | 8 | 2025 | 61023 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2025 | 13997 | 0.120 |
Why?
|
| Astrocytoma | 1 | 2016 | 100 | 0.120 |
Why?
|
| Female | 9 | 2025 | 66304 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2024 | 3065 | 0.110 |
Why?
|
| Brain | 2 | 2023 | 2981 | 0.100 |
Why?
|
| Histones | 1 | 2016 | 526 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2016 | 326 | 0.100 |
Why?
|
| Follow-Up Studies | 4 | 2025 | 5129 | 0.100 |
Why?
|
| Sulindac | 1 | 2011 | 5 | 0.100 |
Why?
|
| Thiones | 1 | 2011 | 9 | 0.100 |
Why?
|
| Naproxen | 1 | 2011 | 20 | 0.100 |
Why?
|
| Growth Inhibitors | 1 | 2011 | 38 | 0.100 |
Why?
|
| Hydrogen Sulfide | 1 | 2011 | 11 | 0.100 |
Why?
|
| Infant | 2 | 2024 | 12465 | 0.100 |
Why?
|
| Ibuprofen | 1 | 2011 | 41 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3549 | 0.090 |
Why?
|
| Aspirin | 1 | 2011 | 224 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 307 | 0.080 |
Why?
|
| Obesity | 1 | 2019 | 2262 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 2286 | 0.060 |
Why?
|
| New York City | 1 | 2024 | 59 | 0.060 |
Why?
|
| History, 18th Century | 1 | 2024 | 70 | 0.060 |
Why?
|
| Hospitals, Public | 1 | 2024 | 42 | 0.060 |
Why?
|
| Autografts | 1 | 2024 | 27 | 0.060 |
Why?
|
| Occipital Bone | 1 | 2024 | 21 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2024 | 116 | 0.060 |
Why?
|
| Bone Transplantation | 1 | 2024 | 49 | 0.060 |
Why?
|
| Punctures | 1 | 2023 | 55 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2024 | 267 | 0.050 |
Why?
|
| Young Adult | 3 | 2025 | 9000 | 0.050 |
Why?
|
| Methicillin | 1 | 2022 | 43 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2024 | 382 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1650 | 0.050 |
Why?
|
| Titanium | 1 | 2022 | 20 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2023 | 319 | 0.050 |
Why?
|
| Skull Base | 1 | 2022 | 54 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2023 | 122 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2024 | 241 | 0.050 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 119 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 174 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2023 | 384 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 458 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1085 | 0.040 |
Why?
|
| Comorbidity | 1 | 2023 | 1530 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 1021 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2019 | 221 | 0.040 |
Why?
|
| Length of Stay | 1 | 2023 | 1303 | 0.040 |
Why?
|
| Registries | 1 | 2024 | 1421 | 0.040 |
Why?
|
| Disease Progression | 1 | 2022 | 2044 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 831 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 29359 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2019 | 1556 | 0.030 |
Why?
|
| Middle Aged | 2 | 2022 | 26601 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2427 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1137 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 1900 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6283 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1782 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 3330 | 0.010 |
Why?
|